Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

Thermal immuno-nanomedicine in cancer
Zhe Yang, Di Gao, Jing Zhao, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 2, pp. 116-134
Closed Access | Times Cited: 149
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 65
Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment
Changhong Zhao, Xinshu Zhu, Jianmei Tan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116113-116113
Open Access | Times Cited: 31
Advances and applications of nanoparticles in cancer therapy
Xianzhou Huang, Tao He, Xiuqi Liang, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 31
Tumor-associated macrophage-related strategies for glioma immunotherapy
Fansong Tang, Yuelong Wang, Yunhui Zeng, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 39
The Importance of M1-and M2-Polarized Macrophages in Glioma and as Potential Treatment Targets
Jiangbin Ren, Bangjie Xu, Jianghao Ren, et al.
Brain Sciences (2023) Vol. 13, Iss. 9, pp. 1269-1269
Open Access | Times Cited: 25
CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review
Emir Begagić, Hakija Bečulić, Nermin Đuzić, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 238-238
Open Access | Times Cited: 17
Glioma-associated macrophages: unraveling their dual role in the microenvironment and therapeutic implications
Jiachen Wang, Shenglan Li, Yanjie Lan, et al.
Current Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 10
Origin, activation, and targeted therapy of glioma-associated macrophages
Can Xu, Menglin Xiao, Xiang Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Oncolytic viral therapy for gliomas: Advances in the mechanisms and approaches to delivery
Alexander Romanishin, A. Yu. Vasil’ev, E Khasanshin, et al.
Virology (2024) Vol. 593, pp. 110033-110033
Open Access | Times Cited: 8
PD-1/PD-L1 axis is involved in the interaction between microglial polarization and glioma
Xipeng Wang, Wei Guo, Ye-Fan Chen, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112074-112074
Closed Access | Times Cited: 4
Targeting the depletion of M2 macrophages: implication in cancer immunotherapy
Talia Festekdjian, Benjamin Bonavida
Critical Reviews™ in Oncogenesis (2024) Vol. 29, Iss. 4, pp. 55-73
Closed Access | Times Cited: 4
RNA lipid nanoparticles as efficient in vivo CRISPR-Cas9 gene editing tool for therapeutic target validation in glioblastoma cancer stem cells
Nadia Rouatbi, Adam A. Walters, Pedro M. Costa, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 776-787
Open Access | Times Cited: 4
CRISPR-Cas9-mediated deletion of carbonic anhydrase 2 in the ciliary body to treat glaucoma
Jiaxuan Jiang, Kangjie Kong, Xiuli Fang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101524-101524
Open Access | Times Cited: 4
Immune checkpoint expression and therapeutic implications in IDH1-mutant and wild-type glioblastomas
Avaniyapuram Kannan Murugan, Siddarth Kannan, Ali S. Alzahrani
Current Problems in Cancer (2025) Vol. 55, pp. 101182-101182
Closed Access
CRISPR-Cas9 Gene Editing for Targeting Cancer Stem Cells in Glioblastoma Multiforme
Saifullah Khan Mahar, Ali Amara, Ammara Ali, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 2, pp. 394-407
Closed Access
Programmed Death-1 Ligand 1 Domain Organization, Signaling Motifs, and Interactors in Cancer Immunotherapy
David Escors, Luisa Chocarro, Miriam Echaide, et al.
Cancers (2025) Vol. 17, Iss. 10, pp. 1635-1635
Open Access
Isorhamnetin Regulates Programmed Death Ligand-1 Expression by Suppressing the EGFR–STAT3 Signaling Pathway in Canine Mammary Tumors
Chen Mei, Xue Zhang, Yan Zhi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 670-670
Open Access | Times Cited: 3
Nanoparticle-Based Approaches in the Diagnosis and Treatment of Brain Tumors
Parvin Pourmasoumi, Seyed Abdolvahab Banihashemian, Farshid Zamani, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7449-7449
Open Access | Times Cited: 3
Novel macrophage-related gene prognostic index for glioblastoma associated with M2 macrophages and T cell dysfunction
Hang Ji, Zhihui Liu, Fang Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Exploration of the pneumocandin biosynthetic gene cluster based on efficient CRISPR/Cas9 gene editing strategy in Glarea lozoyensis
Kaili Jiang, Yating Jin, Pan Luo, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135220-135220
Closed Access | Times Cited: 2
Revolutionizing personalized cancer treatment: the synergy of next-generation sequencing and CRISPR/Cas9
Muniba Mahmood, Izza Taufiq, Sidra Mazhar, et al.
Personalized Medicine (2024) Vol. 21, Iss. 3, pp. 175-190
Closed Access | Times Cited: 1
Combination of tumor antigen drainage and immune activation to promote a cancer-immunity cycle against glioblastoma
Xu Han, Xiaomei Zhao, Jincai Luo
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 1
Systems Medicine for Precise Targeting of Glioblastoma
Jie Zeng, Xiao Xue Zeng
Molecular Biotechnology (2023) Vol. 65, Iss. 10, pp. 1565-1584
Open Access | Times Cited: 2
The Application of CRISPR-Cas System in Glioblastoma Research and Treatment
Jiaqi Feng
BIO Web of Conferences (2023) Vol. 60, pp. 01011-01011
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top